Initial Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Initial clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial

Spinal Cord InjuriesSpinal Cord Injury (SCI), Initial Encounter
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal102 enrolled1 locationNCT07472985
Recruiting
Phase 1

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

First in Man Study to Evaluate Initial Safety
Gliknik Inc.70 enrolled1 locationNCT05318534
Recruiting
Phase 2Phase 3

Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo

Post-aggressive ImmunosuppressionAdult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
Assistance Publique - Hôpitaux de Paris170 enrolled2 locationsNCT06694740
Recruiting

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

IgA Nephropathy (IgAN)Early Initial Therapy
Sichuan Provincial People's Hospital200 enrolled1 locationNCT06676007
Recruiting

Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema

TreatmentRefractoryMicropulse Laser+2 more
The General Authority for Teaching Hospitals and Institutes50 enrolled1 locationNCT07295704
Recruiting
Not Applicable

Assessment of Neural Signals for the Control of Assistive Devices

Spinal Cord Injury (SCI), Initial Encounter
University of Miami3 enrolled2 locationsNCT06533969
Recruiting
Not Applicable

Clinical Evaluation of Remineralizing Potential of Remineralizing Agents on WSLs Managment

White Spot Lesion of ToothInitial Dental Caries
Mansoura University120 enrolled1 locationNCT07111403
Recruiting
Phase 2

Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL

Initial MZLUntreated MZLBTKi+1 more
Li Zhiming33 enrolled2 locationsNCT06985472
Recruiting
Phase 4

A Randomized Controlled Trial of Vitamin D Supplementation on Salivary Biomarkers and Cariogenic Oral Microbiome

Dental CariesWhite Spot LesionInitial Caries+1 more
Dow University of Health Sciences90 enrolled1 locationNCT06172764
Recruiting

Wearable Device-Based Analysis of the Relationship Between Sleep Patterns and Clinical Prognosis in Patients With Traumatic Brain Injury

Traumatic Brain Injury (TBI); Concussion, Initial Encounter
General Hospital of Ningxia Medical University50 enrolled1 locationNCT06790979
Recruiting

Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer

Esophageal Squamous Cell CarcinomaChemoradiotherapyInitial Inoperable
Anhui Provincial Hospital97 enrolled1 locationNCT06190847
Recruiting
Phase 2

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD50 enrolled1 locationNCT05757336